IMRX · Forms 3, 4, 5
Insider trades at Immuneering Corp
No open-market insider buys or sells at Immuneering Corp in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Immuneering Corp (IMRX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Immuneering Corp in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Andrew Gengos | Chief Financial Officer | Options or other derivatives | Form 4 | ||||
| Andrew Gengos | Chief Financial Officer | Became an insider (Form 3) | Form 3 | ||||
| Benjamin J. Zeskind | PRESIDENT AND CEO | Buy | 2,400 | $4.56 | $11K | Form 4 | |
| Brett Matthew Hall | CHIEF SCIENTIFIC OFFICER | Buy | 6,035 | $4.15 | $25K | Form 4 | |
| Thomas J. Schall | Director | Options or other derivatives | Form 4 | ||||
| Diana Hausman | Director | Options or other derivatives | Form 4 | ||||
| Robert J Carpenter | Director | Options or other derivatives | Form 4 | ||||
| Laurie Keating | Director | Options or other derivatives | Form 4 | ||||
| Peter Feinberg | Director | Options or other derivatives | Form 4 | ||||
| Leah R Neufeld | CHIEF PEOPLE OFFICER | Award | 3,628 | $4.29 | $16K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.